Profil
Bridget O'Keeffe worked as Senior Director-Clinical Development at Nektar Therapeutics.
From 2021 to 2023, Dr. O'Keeffe was Vice President-Clinical Development at OncoSec Medical, Inc. Education includes undergraduate studies at Case Western Reserve University and a doctorate from the University of California, Berkeley.
Anciens postes connus de Bridget O'Keeffe
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Corporate Officer/Principal | 01/06/2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Bridget O'Keeffe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















